IP Verse

Engineered Anti-Il-23 Antibodies

Patent No. EP1931710 (titled "Engineered Anti-Il-23 Antibodies") was filed by Merck Sharp & Dohme on Aug 29, 2006. The application was issued on Jan 18, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABBVIEOct 18, 2017KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF
ABBVIE OVERSEAS RLOct 18, 2017KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF
ELI LILLYOct 10, 2017BIJVANK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1931710

MERCK SHARP & DOHME
Application Number
EP06802592A
Filing Date
Aug 29, 2006
Status
Revoked
May 26, 2023
Publication Date
Jan 18, 2017
External Links
Slate, Register , Google Patents